Financial Instruments Schedule of Long-Term Debt Instruments (Tables)

12 Months Ended

Jun. 26, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Available-for-sale Securities [Table Text Block]

Fair values were as follows:

	June 26, 2021								June 27, 2020
	Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss		Estimated Fair Value		Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss		Estimated Fair Value
	(in thousands)
Available-for-sale investments:
Corporate debt securities	$	—	$	—	$	—	$	—	$	35,417	$	137	$	(18)	$	35,536
Total available-for-sale investments	$	—	$	—	$	—	$	—	$	35,417	$	137	$	(18)	$	35,536

Schedule of Long-term Debt Instruments [Table Text Block]

Outstanding debt obligations

The following table summarizes the Company's outstanding debt obligations:

	June 26, 2021		June 27, 2020
	(in thousands)
3.375% fixed rate notes due March 2023	$	500,000	$	500,000
3.45% fixed rate notes due June 2027	500,000		500,000
Total outstanding debt	1,000,000		1,000,000
Less: Reduction for unamortized discount and debt issuance costs	(4,540)		(5,978)
Total long-term debt	$	995,460	$	994,022

Derivative Instruments, Gain (Loss) [Table Text Block]

Effect of hedge accounting on the Consolidated Statements of Income

The following table summarizes the gains and (losses) from hedging activities recognized in the Company's Consolidated Statements of Income:

	June 26, 2021						June 27, 2020
	Net Revenue		Cost of Goods Sold		Operating Expenses		Net Revenue		Cost of Goods Sold		Operating Expenses
	(in thousands)
Income and expenses line items in which the effects of cash flow hedges are recorded	$	2,632,529	$	872,183	$	814,646	$	2,191,395	$	758,743	$	746,258
Gain (loss) on cash flow hedges:
Foreign exchange contracts:
Gain (loss) reclassified from accumulated other comprehensive income into income	$	—	$	796	$	2,117	$	—	$	(42)	$	(1,535)